Company / Operating Cash Flow
Zomedica Corp. Operating Cash Flow History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$17.6M
FY2025
5-year range
-$23.6M / -$11.7M
FY2022-FY2025
Trend
+25.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$18M.
Based on SEC 10-K filings.
-$18M in FY2025.
Declined from -$16M to -$18M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 25.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$17.6M | +25.3% |
| FY2024 | -$23.6M | -47.9% |
| FY2023 | -$16.0M | -36.9% |
| FY2022 | -$11.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026